Valisure was founded in 2015 by Adam Clark-Joseph and David Light.[2] After taking an anticonvulsant medication and experiencing negative side effects due to the poor quality of the drug, Clark-Joseph contacted Light about establishing a business testing pharmaceutical products.[2] Valisure was originally established as a pharmacy, which, unlike typical pharmacies, tested drugs before distributing them.[1] Valisure divested of the pharmacy business in 2021, opting instead to focus on testing.[1]
In 2019, Valisure reported that it had tested Zantac and generic equivalents and discovered that they contained N-Nitrosodimethylamine, which is thought to be a carcinogen.[3] In 2021, Johnson & Johnson recalled sun tan lotions after Valisure discovered they contained high levels of benzene.[3][4][5]
In February 2024, Valisure announced Chip Phillips as their new CEO, succeeding David Light. They also announced funding from AlleyCorp and Connecticut Innovations.[6]
Clients of Valisure include Kaiser Permanente and the United States Armed Forces.[2][7]
